Cyclic amine derivative or salt thereof

A compound useful as an NMDA antagonist having a wide safety region which is a therapeutic agent for Alzheimer's disease, vascular dementia (vascular agnosia), Parkinson's disease, ischemic apoplexy, and pains or a preventive agent for these. The compound is an amine derivative or salt the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: YAMASAKI, SHINGO, SUZUKI, DAISUKE, KANAYAMA, TAKATOSHI, TOBE, TAKAHIKO, MAENO, KYOICHI, KAWABATA, SHIGEKI, HAYASHIBE, SATOSHI, OHMORI, JUNYA, HOSHII, HIROAKI, SUZUKI, JOTAROU, SHIRAISHI, NOBUYUKI, SHITAKA, YOSHITSUGU
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator YAMASAKI, SHINGO
SUZUKI, DAISUKE
KANAYAMA, TAKATOSHI
TOBE, TAKAHIKO
MAENO, KYOICHI
KAWABATA, SHIGEKI
HAYASHIBE, SATOSHI
OHMORI, JUNYA
HOSHII, HIROAKI
SUZUKI, JOTAROU
SHIRAISHI, NOBUYUKI
SHITAKA, YOSHITSUGU
description A compound useful as an NMDA antagonist having a wide safety region which is a therapeutic agent for Alzheimer's disease, vascular dementia (vascular agnosia), Parkinson's disease, ischemic apoplexy, and pains or a preventive agent for these. The compound is an amine derivative or salt thereof characterized by comprising an amine-containing structure (A) and a di- or tricyclic fused ring (indane, tetralone, 4,5,6,7-tetrahydrobenzothiophene, 4,5,6,7-tetrahydrobenzofuran, 7,8-dihydro-6H-indeno[4,5-b]furan, 2,3-dihydro-1H-cyclopenta[a]naphthalene, etc.) bonded to the structure (A) through X (a bond, lower alkylene, etc.). The NMDA antagonist contains the derivative or salt as an active ingredient.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2005285878BB2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2005285878BB2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2005285878BB23</originalsourceid><addsrcrecordid>eNrjZFB3rkzOyUxWSMzNzEtVSEktyixLLMksS1XIL1IoTswpUSjJSC1KzU_jYWBNS8wpTuWF0twMKm6uIc4euqkF-fGpxQWJyal5qSXxjqFGBgamRhamFuYWTk5GxkQqAwB94Ck4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Cyclic amine derivative or salt thereof</title><source>esp@cenet</source><creator>YAMASAKI, SHINGO ; SUZUKI, DAISUKE ; KANAYAMA, TAKATOSHI ; TOBE, TAKAHIKO ; MAENO, KYOICHI ; KAWABATA, SHIGEKI ; HAYASHIBE, SATOSHI ; OHMORI, JUNYA ; HOSHII, HIROAKI ; SUZUKI, JOTAROU ; SHIRAISHI, NOBUYUKI ; SHITAKA, YOSHITSUGU</creator><creatorcontrib>YAMASAKI, SHINGO ; SUZUKI, DAISUKE ; KANAYAMA, TAKATOSHI ; TOBE, TAKAHIKO ; MAENO, KYOICHI ; KAWABATA, SHIGEKI ; HAYASHIBE, SATOSHI ; OHMORI, JUNYA ; HOSHII, HIROAKI ; SUZUKI, JOTAROU ; SHIRAISHI, NOBUYUKI ; SHITAKA, YOSHITSUGU</creatorcontrib><description>A compound useful as an NMDA antagonist having a wide safety region which is a therapeutic agent for Alzheimer's disease, vascular dementia (vascular agnosia), Parkinson's disease, ischemic apoplexy, and pains or a preventive agent for these. The compound is an amine derivative or salt thereof characterized by comprising an amine-containing structure (A) and a di- or tricyclic fused ring (indane, tetralone, 4,5,6,7-tetrahydrobenzothiophene, 4,5,6,7-tetrahydrobenzofuran, 7,8-dihydro-6H-indeno[4,5-b]furan, 2,3-dihydro-1H-cyclopenta[a]naphthalene, etc.) bonded to the structure (A) through X (a bond, lower alkylene, etc.). The NMDA antagonist contains the derivative or salt as an active ingredient.</description><language>eng</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; CHEMISTRY ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20110630&amp;DB=EPODOC&amp;CC=AU&amp;NR=2005285878B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20110630&amp;DB=EPODOC&amp;CC=AU&amp;NR=2005285878B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>YAMASAKI, SHINGO</creatorcontrib><creatorcontrib>SUZUKI, DAISUKE</creatorcontrib><creatorcontrib>KANAYAMA, TAKATOSHI</creatorcontrib><creatorcontrib>TOBE, TAKAHIKO</creatorcontrib><creatorcontrib>MAENO, KYOICHI</creatorcontrib><creatorcontrib>KAWABATA, SHIGEKI</creatorcontrib><creatorcontrib>HAYASHIBE, SATOSHI</creatorcontrib><creatorcontrib>OHMORI, JUNYA</creatorcontrib><creatorcontrib>HOSHII, HIROAKI</creatorcontrib><creatorcontrib>SUZUKI, JOTAROU</creatorcontrib><creatorcontrib>SHIRAISHI, NOBUYUKI</creatorcontrib><creatorcontrib>SHITAKA, YOSHITSUGU</creatorcontrib><title>Cyclic amine derivative or salt thereof</title><description>A compound useful as an NMDA antagonist having a wide safety region which is a therapeutic agent for Alzheimer's disease, vascular dementia (vascular agnosia), Parkinson's disease, ischemic apoplexy, and pains or a preventive agent for these. The compound is an amine derivative or salt thereof characterized by comprising an amine-containing structure (A) and a di- or tricyclic fused ring (indane, tetralone, 4,5,6,7-tetrahydrobenzothiophene, 4,5,6,7-tetrahydrobenzofuran, 7,8-dihydro-6H-indeno[4,5-b]furan, 2,3-dihydro-1H-cyclopenta[a]naphthalene, etc.) bonded to the structure (A) through X (a bond, lower alkylene, etc.). The NMDA antagonist contains the derivative or salt as an active ingredient.</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>CHEMISTRY</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2011</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFB3rkzOyUxWSMzNzEtVSEktyixLLMksS1XIL1IoTswpUSjJSC1KzU_jYWBNS8wpTuWF0twMKm6uIc4euqkF-fGpxQWJyal5qSXxjqFGBgamRhamFuYWTk5GxkQqAwB94Ck4</recordid><startdate>20110630</startdate><enddate>20110630</enddate><creator>YAMASAKI, SHINGO</creator><creator>SUZUKI, DAISUKE</creator><creator>KANAYAMA, TAKATOSHI</creator><creator>TOBE, TAKAHIKO</creator><creator>MAENO, KYOICHI</creator><creator>KAWABATA, SHIGEKI</creator><creator>HAYASHIBE, SATOSHI</creator><creator>OHMORI, JUNYA</creator><creator>HOSHII, HIROAKI</creator><creator>SUZUKI, JOTAROU</creator><creator>SHIRAISHI, NOBUYUKI</creator><creator>SHITAKA, YOSHITSUGU</creator><scope>EVB</scope></search><sort><creationdate>20110630</creationdate><title>Cyclic amine derivative or salt thereof</title><author>YAMASAKI, SHINGO ; SUZUKI, DAISUKE ; KANAYAMA, TAKATOSHI ; TOBE, TAKAHIKO ; MAENO, KYOICHI ; KAWABATA, SHIGEKI ; HAYASHIBE, SATOSHI ; OHMORI, JUNYA ; HOSHII, HIROAKI ; SUZUKI, JOTAROU ; SHIRAISHI, NOBUYUKI ; SHITAKA, YOSHITSUGU</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2005285878BB23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2011</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>CHEMISTRY</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>YAMASAKI, SHINGO</creatorcontrib><creatorcontrib>SUZUKI, DAISUKE</creatorcontrib><creatorcontrib>KANAYAMA, TAKATOSHI</creatorcontrib><creatorcontrib>TOBE, TAKAHIKO</creatorcontrib><creatorcontrib>MAENO, KYOICHI</creatorcontrib><creatorcontrib>KAWABATA, SHIGEKI</creatorcontrib><creatorcontrib>HAYASHIBE, SATOSHI</creatorcontrib><creatorcontrib>OHMORI, JUNYA</creatorcontrib><creatorcontrib>HOSHII, HIROAKI</creatorcontrib><creatorcontrib>SUZUKI, JOTAROU</creatorcontrib><creatorcontrib>SHIRAISHI, NOBUYUKI</creatorcontrib><creatorcontrib>SHITAKA, YOSHITSUGU</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>YAMASAKI, SHINGO</au><au>SUZUKI, DAISUKE</au><au>KANAYAMA, TAKATOSHI</au><au>TOBE, TAKAHIKO</au><au>MAENO, KYOICHI</au><au>KAWABATA, SHIGEKI</au><au>HAYASHIBE, SATOSHI</au><au>OHMORI, JUNYA</au><au>HOSHII, HIROAKI</au><au>SUZUKI, JOTAROU</au><au>SHIRAISHI, NOBUYUKI</au><au>SHITAKA, YOSHITSUGU</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Cyclic amine derivative or salt thereof</title><date>2011-06-30</date><risdate>2011</risdate><abstract>A compound useful as an NMDA antagonist having a wide safety region which is a therapeutic agent for Alzheimer's disease, vascular dementia (vascular agnosia), Parkinson's disease, ischemic apoplexy, and pains or a preventive agent for these. The compound is an amine derivative or salt thereof characterized by comprising an amine-containing structure (A) and a di- or tricyclic fused ring (indane, tetralone, 4,5,6,7-tetrahydrobenzothiophene, 4,5,6,7-tetrahydrobenzofuran, 7,8-dihydro-6H-indeno[4,5-b]furan, 2,3-dihydro-1H-cyclopenta[a]naphthalene, etc.) bonded to the structure (A) through X (a bond, lower alkylene, etc.). The NMDA antagonist contains the derivative or salt as an active ingredient.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_AU2005285878BB2
source esp@cenet
subjects ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
title Cyclic amine derivative or salt thereof
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T22%3A08%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=YAMASAKI,%20SHINGO&rft.date=2011-06-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2005285878BB2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true